Cannabinoids and the Treatment of Fibromyalgia
Cannabinoids offer a new frontier in the treatment of this debilitating disease.
Read more
Media
- News
News
Exploring the Untapped Potential: European Venture Funds in Niche Investment Areas
Sector specific funds outperform generalist contemporaries in key metrics according to published data.
Read moreGermany reveals new cannabinoid legislation
Germany's diminished recreational framework is a positive for the therapeutic sector.
Read moreNext generation drug discovery & ECS therapies
Synthetic biology is revolutionising the development of highly specific drugs, including those that target the endocannabinoid system.
Read moreWhat’s driving growth in the endocannabinoid therapeutics sector?
A range of factors are coming together to the sector's benefit.
Read moreSignificant Exits in the Global MedCan Market
A number of multi billion dollar exits in the sector show the viability and potential of early stage medicinal cannabis…
Read moreA brilliant start to 2023 for the UK’s cannabinoid sector
January 2023 has been a month of positives for the UK medicinal cannabis sector.
Read moreÓskare’s 2022 market predictions come to fruition
Óskare Capital correctly called a range of key sector events in 2022.
Read moreFamily Offices Boost Private Equity Investment For 2023
North American family offices are increasing private equity portfolio allocation in 2023.
Read moreHow Medical Cannabis is Revolutionising Chronic Pain Management
Medical cannabis is providing doctors with a range of new treatments for chronic pain conditions.
Read moreGermany’s plan for legalisation flips its current supply model
Germany’s plan for legalisation changes its current supply model
Read morePODCAST: The UK Cannabis Investment Landscape
Canverse and Oskare Capital discuss the UK Cannabis Investment Landscape
Read moreGuest Post: The Symbiosis of Regulation and Science – Óskare Capital SAS
ÓSKARE Fund I & Medical Cannabinoids
Read moreÓSKARE CAPITAL STRENGTHENS TEAM WITH TWO NEW MEMBERS
Óskare Capital is pleased to announce that Oliver Lamb will be joining as Co-Founder and Investment Manager in the investment…
Read moreThe Medical Cannabis Opportunity in the EU Stimulus Package
The good news for Europe’s Medical Cannabis industry is that, although not specifically named, the sector has touch points in…
Read moreBroughton bids farewell to Mercia
Mercia Asset Management has lost its investment director and university lead Nicola Broughton to a new $171m fund targeting the…
Read moreCentral Bank signs off on €150m legal cannabis fund
THE Central Bank of Ireland has given the green light for an Irish domiciled investment fund that is seeking to…
Read moreMedical cannabis private equity fund established
Ireland's first ever private equity medical cannabis fund has been established. The new venture has been set up by Crossroads…
Read moreCannabis thérapeutique : un fonds veut doper l’écosystème européen
Oskare Capital lance Oskare Fund I, un fonds d'investissement qui va cibler des sociétés européennes développant des thérapies à base…
Read moreOctarine receives funding to develop biosynthetic platform for cannabinoid and psilocybin derivatives
Octarine Bio IVS (“Octarine” or the “Company”), a synthetic biology company developing functionally superior cannabinoid and psilocybin derivatives using microbial…
Read more